Detalhe da pesquisa
1.
Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
Blood
; 143(10): 933-937, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194681
2.
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.
Blood
; 140(1): 25-37, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507686
3.
Targeting hyperactive platelet-derived growth factor receptor-ß signaling in T-cell acute lymphoblastic leukemia and lymphoma.
Haematologica
; 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941480
4.
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
Blood
; 135(19): 1685-1695, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315407
5.
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemia.
Br J Haematol
; 194(1): 28-43, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942287
6.
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
Blood
; 134(17): 1415-1429, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501154
7.
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
Blood
; 129(24): 3221-3226, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270453
8.
ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
Haematologica
; 109(5): 1325-1327, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105739
9.
Notch signaling: switching an oncogene to a tumor suppressor.
Blood
; 123(16): 2451-9, 2014 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608975
10.
Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia.
Blood
; 124(1): 106-10, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24787007
11.
In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation.
Br J Haematol
; 188(4): e53-e57, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900929
12.
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
Br J Haematol
; 190(4): e189-e191, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584418
13.
Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.
Br J Haematol
; 168(2): 230-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25256574
14.
Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Gastroenterology
; 147(4): 882-892.e8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998203
15.
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
Br J Haematol
; 161(1): 117-27, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23373539
16.
Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial.
Haematologica
; 103(7): e288-e292, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519867
17.
The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 41(19): 3545-3556, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098241
18.
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Cancers (Basel)
; 15(3)2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765607
19.
Therapeutic targeting of "undruggable" MYC.
EBioMedicine
; 75: 103756, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942444
20.
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.
J Clin Invest
; 118(9): 3143-50, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18688286